Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c14b7a5c959643f4d911b0597706fdd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f72c012dd58d936db8f5f42c39ebd54a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb0f3b9b233b0cdd546c13570f5914f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a16aacb7cb1b371dbe84d231a06aa552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f32e3c50b9c03233fbd6f811aa88b2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_246fec6db4944ea64e8094341e128d0f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
filingDate |
2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82295e92d256277efa8c236c9ec19a59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_443787b39e9756e01cd37ee6f21d74f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d2cd15f324506003677d71f8ee846be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d31eb137fa65eeb478f77401bd3e14da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7239e0070d1e0f68f9f854cb4c6431d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f37c80cfa722073fec39122e6d13c4d |
publicationDate |
2011-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2011212993-A1 |
titleOfInvention |
Medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
abstract |
The invention relates to an ophthalmic medicament for treating glaucoma which comprises a clathrate compound prepared by dissolving cilostazol or a salt thereof in a cyclodextrin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9206129-B2 |
priorityDate |
2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |